Evidence map›Paper›PMID 34977527›Full record

ArticleMaterials today. Bio2022

3D-bioprinted peptide coupling patches for wound healing.

Gaopeng Guan, Qizhuang Lv, Shengyuan Liu, Zhenzhen Jiang, Chunxia Zhou, Weifang Liao

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Materials today. Bio, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Cu-FeACS omega · 2025
    Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Review
  12. Review
  13. Review
  14. Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. A review with updated perspectives on in vitro and in vivo wound healing models.Turkish journal of biology = Turk biyoloji dergisi · 2023
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Gaopeng GuanClinical Medical College Jiujiang University Hospital, Jiujiang University, Jiujiang, 332000, Jiangxi, China.
Qizhuang LvCollege of Biology & Pharmacy, Yulin Normal University, Yulin, 537000, Guangxi, China.
Shengyuan LiuLongyan People Hospital of Fujian, Pneumology Department, Longlan, 361000, Fujian, China.
Zhenzhen JiangClinical Medical College Jiujiang University Hospital, Jiujiang University, Jiujiang, 332000, Jiangxi, China.
Chunxia ZhouClinical Medical College Jiujiang University Hospital, Jiujiang University, Jiujiang, 332000, Jiangxi, China.
Weifang LiaoClinical Medical College Jiujiang University Hospital, Jiujiang University, Jiujiang, 332000, Jiangxi, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chronic wounds caused by severe trauma remain a serious challenge for clinical treatment. In this study, we developed a novel angiogenic 3D-bioprinted peptide patch to improve skin wound healing. The 3D-bioprinted technology can fabricate individual patches according to the shape characteristics of the damaged tissue. Gelatin methacryloyl (GelMA) and hyaluronic acid methacryloyl (HAMA) have excellent biocompatibility and biodegradability, and were used as a biomaterial to produce bioprinted patches. The pro-angiogenic QHREDGS peptide was covalently conjugated to the 3D-bioprinted GelMA/HAMA patches, extending the release of QHREDGS and improving the angiogenic properties of the patch. Our results demonstrated that these 3D-bioprinted peptide patches showed excellent biocompatibility, angiogenesis, and tissue repair both

Indexed as

3D-printingAngiogenesisGelatin methacryloyl (GelMA)Hyaluronic acid methacryloyl (HAMA)PeptideWound healing

Identifiers

PMID34977527
PMCPMC8683759

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.